ALBERTDAVD Stock Overview
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 6/6 |
My Notes
NewNotes are coming soon
Albert David Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹550.15 |
| 52 Week High | ₹727.40 |
| 52 Week Low | ₹486.85 |
| Beta | 0.23 |
| 1 Month Change | -3.46% |
| 3 Month Change | -8.35% |
| 1 Year Change | -18.67% |
| 3 Year Change | 8.34% |
| 5 Year Change | 43.98% |
| Change since IPO | 76.19% |
Recent News & Updates
Recent updates
Here's Why We Think Albert David (NSE:ALBERTDAVD) Is Well Worth Watching
Feb 14
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Albert David Limited's (NSE:ALBERTDAVD) CEO For Now
Sep 08Calculating The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Feb 06Do Fundamentals Have Any Role To Play In Driving Albert David Limited's (NSE:ALBERTDAVD) Stock Up Recently?
Jan 22
Why Albert David's (NSE:ALBERTDAVD) CEO Pay Matters
Jan 07Have Insiders Been Buying Albert David Limited (NSE:ALBERTDAVD) Shares?
Dec 23Here's Why Albert David's (NSE:ALBERTDAVD) Statutory Earnings Are Arguably Too Conservative
Dec 08Should You Or Shouldn't You: A Dividend Analysis on Albert David Limited (NSE:ALBERTDAVD)
Nov 23A Look At The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Nov 08Should Weakness in Albert David Limited's (NSE:ALBERTDAVD) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Oct 13Is Now The Time To Put Albert David (NSE:ALBERTDAVD) On Your Watchlist?
Sep 28What Does Albert David's (NSE:ALBERTDAVD) CEO Pay Reveal?
Sep 13Are Insiders Buying Albert David Limited (NSE:ALBERTDAVD) Stock?
Aug 28Should You Buy Albert David Limited (NSE:ALBERTDAVD) For Its Dividend?
Aug 10A Look At The Fair Value Of Albert David Limited (NSE:ALBERTDAVD)
Aug 10Albert David Limited (NSE:ALBERTDAVD) Might Not Be As Mispriced As It Looks
Jul 20Shareholder Returns
| ALBERTDAVD | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 2.1% | -1.2% | -1.1% |
| 1Y | -18.7% | -8.1% | -3.4% |
Return vs Industry: ALBERTDAVD underperformed the Indian Pharmaceuticals industry which returned -8.7% over the past year.
Return vs Market: ALBERTDAVD underperformed the Indian Market which returned -4.1% over the past year.
Price Volatility
| ALBERTDAVD volatility | |
|---|---|
| ALBERTDAVD Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 4.7% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 3.4% |
Stable Share Price: ALBERTDAVD is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: ALBERTDAVD's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1938 | 1,326 | n/a | https://www.albertdavidindia.com |
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company also exports its products to Latin American, Southeast Asian, and other African countries.
Albert David Limited Fundamentals Summary
| ALBERTDAVD fundamental statistics | |
|---|---|
| Market Cap | ₹3.14b |
| Earnings (TTM) | ₹340.34m |
| Revenue (TTM) | ₹3.32b |
9.2x
P/E Ratio0.9x
P/S RatioIs ALBERTDAVD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALBERTDAVD income statement (TTM) | |
|---|---|
| Revenue | ₹3.32b |
| Cost of Revenue | ₹1.21b |
| Gross Profit | ₹2.10b |
| Other Expenses | ₹1.76b |
| Earnings | ₹340.34m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 59.63 |
| Gross Margin | 63.42% |
| Net Profit Margin | 10.26% |
| Debt/Equity Ratio | 0% |
How did ALBERTDAVD perform over the long term?
See historical performance and comparison